Pain relief devoid of opioid side effects following central action of a silylated neurotensin analog.

European Journal of Pharmacology
Pascal TétreaultP Sarret

Abstract

Neurotensin (NT) exerts naloxone-insensitive antinociceptive action through its binding to both NTS1 and NTS2 receptors and NT analogs provide stronger pain relief than morphine on a molecular basis. Here, we examined the analgesic/adverse effect profile of a new NT(8-13) derivative denoted JMV2009, in which the Pro10 residue was substituted by a silicon-containing unnatural amino acid silaproline. We first report the synthesis and in vitro characterization (receptor-binding affinity, functional activity and stability) of JMV2009. We next examined its analgesic activity in a battery of acute, tonic and chronic pain models. We finally evaluated its ability to induce adverse effects associated with chronic opioid use, such as constipation and analgesic tolerance or related to NTS1 activation, like hypothermia. In in vitro assays, JMV2009 exhibited high binding affinity for both NTS1 and NTS2, improved proteolytic resistance as well as agonistic activities similar to NT, inducing sustained activation of p42/p44 MAPK and receptor internalization. Intrathecal injection of JMV2009 produced dose-dependent antinociceptive responses in the tail-flick test and almost completely abolished the nociceptive-related behaviors induced by chemi...Continue Reading

References

Oct 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·C B NemeroffA J Prange
Jan 1, 1986·Gastroenterology·K Thor, S Rosell
Feb 1, 1968·British Journal of Pharmacology and Chemotherapy·H O CollierC Schneider
Apr 2, 1983·Lancet·J CalamW S Peart
Oct 1, 1981·Acta Physiologica Scandinavica·P M Hellström, S Rosell
Sep 1, 1994·International Journal of Peptide and Protein Research·D L HeylA E Corbin
Mar 10, 2000·European Journal of Pharmacology·B M Tyler-McMahonE Richelson
Mar 21, 2002·Journal of the American Chemical Society·Florine CavelierMichel Marraud
Mar 1, 1957·British Journal of Pharmacology and Chemotherapy·T J HALEY, W G MCCORMICK
Nov 19, 2003·The Journal of Pain : Official Journal of the American Pain Society·Ewan McNicolUNKNOWN Americal Pain Society
Mar 31, 2004·The Journal of Peptide Research : Official Journal of the American Peptide Society·F CavelierS Sagan
Sep 9, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Philippe SarretAlain Beaudet
Oct 22, 2005·Current Medical Research and Opinion·J DevulderS H Nataraja
Jan 18, 2006·The Journal of Pain : Official Journal of the American Pain Society·Larry F ChuMartin S Angst
Jun 21, 2006·Journal of Peptide Science : an Official Publication of the European Peptide Society·Florine CavelierMichel Marraud
Jul 28, 2006·Peptides·Paul R Dobner
Dec 2, 2006·Nature Reviews. Drug Discovery·John P OveringtonAndrew L Hopkins
Jan 10, 2008·Journal of Neurochemistry·Geneviève RoussyPhilippe Sarret
Mar 5, 2009·Nature Reviews. Neuroscience·Jeffrey S Mogil
May 26, 2009·ACS Chemical Biology·Rebecca M MyersSteven V Ley
Aug 5, 2009·Brain Research·M BoulesE Richelson
Oct 16, 2009·Molecular Interventions·Laura S Stone, Derek C Molliver
Oct 31, 2009·Brain Research·Mona BoulesElliott Richelson
Dec 17, 2009·Journal of Peptide Science : an Official Publication of the European Peptide Society·Georgios A DalkasFlorine Cavelier
Jun 26, 2010·The Journal of Pharmacology and Experimental Therapeutics·Grace C RossiGavril W Pasternak
Jul 24, 2010·British Journal of Pharmacology·Carol KilkennyUNKNOWN NC3Rs Reporting Guidelines Working Group
Mar 31, 2011·Journal of Medicinal Chemistry·Jürgen EinsiedelPeter Gmeiner
May 31, 2011·Physiology & Behavior·Pascal TétreaultPhilippe Sarret
Jun 22, 2011·Behavioural Pharmacology·Mona BoulesElliott Richelson

❮ Previous
Next ❯

Citations

Feb 20, 2021·Behavioural Brain Research·Mélanie VivancosPhilippe Sarret
May 7, 2021·Journal of Medicinal Chemistry·Samuel ObengChristopher R McCurdy

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.